Shimada T, Mitsuhata H, Matsumoto S, Ohtaka K, Hasegawa J
Department of Anesthesiology, Hiraka General Hospital, Yokote.
Masui. 1991 Oct;40(10):1507-12.
We studied the cardiovascular responses to laryngoscopy and intubation in 30 patients who received continuous infusion of either diltiazem 10 micrograms.kg-1.min-1, 40 micrograms.kg-1.min-1 or saline as control group during 20 min before induction. Heart rate, arterial pressure, rate pressure product (RPP), pressure rate quotient (PRQ) were measured starting 20 min before induction to 3 min after tracheal intubation. The increases in arterial pressure and RPP following tracheal intubation were reduced significantly in patients receiving diltiazem 40 micrograms.kg-1.min-1, but they were not reduced in patients receiving diltiazem 10 micrograms.kg-1.min-1 compared with control. We conclude that continuous infusion of diltiazem during 20 min before induction is effective for preventing the increases in arterial pressure and RPP following tracheal intubation, and the optimal infusion rate is from 10 to 40 micrograms.kg-1.min-1.
我们研究了30例患者在诱导前20分钟持续输注地尔硫䓬10微克·千克⁻¹·分钟⁻¹、40微克·千克⁻¹·分钟⁻¹或生理盐水作为对照组时,喉镜检查和气管插管时的心血管反应。从诱导前20分钟开始至气管插管后3分钟测量心率、动脉压、速率压力乘积(RPP)、压力速率商(PRQ)。接受40微克·千克⁻¹·分钟⁻¹地尔硫䓬的患者气管插管后动脉压和RPP的升高明显降低,但与对照组相比,接受10微克·千克⁻¹·分钟⁻¹地尔硫䓬的患者其升高并未降低。我们得出结论,诱导前20分钟持续输注地尔硫䓬可有效预防气管插管后动脉压和RPP的升高,最佳输注速率为10至40微克·千克⁻¹·分钟⁻¹。